Roudie advises life science companies, charities, and public sector clients on political, policy and stakeholder engagement strategies. Roudie is a change maker with a goal of translating complex policy issues into impactful messages, breaking down complex solutions into achievable policy goals. She specialises in stakeholder strategies ahead of medicines launch and to support market access and uptake.
With over 15 years of experience in public policy and campaigning, Roudie was formerly the Head of Government Affairs at the ABPI during the UK Brexit negotiations with the EU, and where she also sat on the ABPI Vaccine Group. Prior to that role, she spent time in industry in Pfizer’s corporate public affairs function. Before joining industry, Roudie worked in the NGO and public sector. As part of Boris Johnson City Hall team, Roudie led the expansion of London’s global life sciences, most notably securing £200m for a UK Dementia Research Institute. Roudie is now a Trustee of the UK Dementia Research Institute, as well as on the Board of the Refugee, Asylum and Migrant Project.
Role:
- Partner at OVID Health
Services offered:
- Advise clients to tell their story and achieve change in the health, social care and life sciences sectors
- Deliver concentrated strategy from a combination of healthcare PR communication and policy approach at a UK and global level
- Bridge the divide between ‘traditional’ healthcare PR, public affairs, campaigns and patient advocacy.